Company Filing History:
Years Active: 2012-2015
Title: Martha E Gadd: Innovator in Ocular Analgesics
Introduction
Martha E Gadd is a notable inventor based in Fort Worth, TX (US). She has made significant contributions to the field of ocular analgesics, holding 2 patents that focus on alleviating ocular pain and treating dry eye symptoms. Her work has the potential to improve the quality of life for many patients suffering from these conditions.
Latest Patents
Martha Gadd's latest patents include innovative formulations and methods for treating ocular pain. One patent discloses the use of certain 2,4-diamino-substituted 1,3-triazines for preventing or alleviating ocular pain in patients. This topical ophthalmic application aims to provide relief for those experiencing discomfort. Another patent focuses on the use of fatty acid amide or inhibitors of fatty acid amide hydrolase (FAAH) for treating dry eye symptoms. This method also addresses the prevention and alleviation of ocular pain, showcasing her commitment to advancing ocular health.
Career Highlights
Throughout her career, Martha has worked with prominent companies such as Novartis AG and Alcon Research, Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas in ocular pharmaceuticals.
Collaborations
Martha has collaborated with esteemed colleagues, including Karen C David and Peter G Klimko. These partnerships have contributed to her success and the advancement of her research in ocular analgesics.
Conclusion
Martha E Gadd is a pioneering inventor whose work in ocular analgesics has the potential to transform patient care. Her patents reflect her dedication to improving ocular health and alleviating pain for those in need.